Literature DB >> 7805029

Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells.

F Incardona1, J M Lewalle, V Morandi, S Lambert, Y Legrand, J M Foidart, C Legrand.   

Abstract

Thrombospondin (TSP), a M(r) 450,000 cytoadhesive glycoprotein, has been shown to potentiate tumor cell metastasis in mice by a mechanism that involves the hemostatic system of the host. In this study, the potential involvement of TSP in the interaction of human mammary adenocarcinoma MCF-7 cells with human umbilical vein endothelial cells (HUVECs) in culture was investigated. Using an ELISA, preconfluent HUVECs synthesized 100-fold more TSP than did MCF-7 cells during 24 h of culture (20 versus 0.2 microgram/10(6) cells). Confocal microscopy localized TSP within intercellular junctions between aggregated MCF-7 cells in suspension. On adherent cells, TSP exhibited a patchy distribution both on the cell surface and in the cytosol. In HUVECs, TSP strongly stained the perinuclear space and was also found in association with cytoskeletal microfibrils. Flow cytometric analysis indicated the presence of a large number of unoccupied receptors for TSP on MCF-7 cells. Binding studies using [125I]TSP demonstrated the presence of 1.6 x 10(6) sites/cell with an apparent Kd of 28 nM. Attachment of radiolabeled MCF-7 cells to a TSP-coated substrate and to HUVEC monolayers was inhibited in the presence of a polyclonal antibody to TSP (10 micrograms/ml) or increasing concentrations (1-10 micrograms/ml) of soluble TSP. Neither nonimmune IgG nor the cell adhesion peptide Gly-Arg-Gly-Asp-Ser (100 micrograms/ml) inhibited these interactions. Inhibition was also observed with heparin (10 micrograms/ml), suggesting the participation of TSP heparin-binding domain(s) and heparin-like molecules. In the presence of an excess of soluble TSP or anti-TSP antibody, MCF-7 cells did not form aggregates in suspension and preformed aggregates were readily dissociated by the addition of soluble TSP. These results indicate that mammary adenocarcinoma cells use TSP to form aggregates and to attach to human endothelial cells. These interactions may have physiological implications during the hematogenous spread of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805029

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Thrombospondin-1 induces tyrosine phosphorylation of adherens junction proteins and regulates an endothelial paracellular pathway.

Authors:  S E Goldblum; B A Young; P Wang; J E Murphy-Ullrich
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

2.  Microdialysis combined with proteomics for protein identification in breast tumor microenvironment in vivo.

Authors:  Baogang J Xu; Wenwei Yan; Bojana Jovanovic; Aubie K Shaw; Qi A An; Jimmy Eng; Anna Chytil; Andrew J Link; Harold L Moses
Journal:  Cancer Microenviron       Date:  2010-04-13

Review 3.  The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature.

Authors:  J F Reavey-Cantwell; R I Haroun; M Zahurak; R E Clatterbuck; R J Parker; R Mehta; J P Fruehauf; H Brem
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

4.  Endothelial cell intracellular Ca2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration.

Authors:  J M Lewalle; D Cataldo; K Bajou; C A Lambert; J M Foidart
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

5.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

6.  beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro.

Authors:  E A Price; D R Coombe; J C Murray
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.

Authors:  John L Frater; Neil E Kay; Charles L Goolsby; Susan E Crawford; Gordon W Dewald; LoAnn C Peterson
Journal:  Diagn Pathol       Date:  2008-04-18       Impact factor: 2.644

Review 8.  Original insights on thrombospondin-1-related antireceptor strategies in cancer.

Authors:  Albin Jeanne; Christophe Schneider; Laurent Martiny; Stéphane Dedieu
Journal:  Front Pharmacol       Date:  2015-10-29       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.